Page last updated: 2024-08-25

rosiglitazone and Bone Diseases, Metabolic

rosiglitazone has been researched along with Bone Diseases, Metabolic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Calzone, R; Cugno, C; Halade, GV; Kizhakayil, D; Rahman, MM; Rahman, SM1

Other Studies

1 other study(ies) available for rosiglitazone and Bone Diseases, Metabolic

ArticleYear
Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies.
    Scientific reports, 2021, 05-14, Volume: 11, Issue:1

    Topics: Adipogenesis; Aging; Animals; Bone Diseases, Metabolic; Cell Differentiation; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Fatty Acids, Omega-3; Female; Humans; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteogenesis; Primary Cell Culture; RAW 264.7 Cells; Rosiglitazone

2021